Inclusion criteria:
Age 25-25 years
Male and female patients
Completion of diagnostic criteria for type 2 diabetes mellitus
The desire to participate in the study with the ability to understand the relevant information and complete the informed consent form
Exclusion criteria:
Use of warfarin and other coumarin substitutes by the patient
Use of increasing blood glucose drugs such as antidepressants (triangles), beta-adrenergic blockers, corticosteroids, diazoxide, diuretics, epinephrine, estrogen, glucagon, isoniazid, lithium, phenothiazines, phenytoin, salicylates and triamterene
Use of glucose lowering drugs, including acetaminophen, alcohol, anabolysin steroids, gemfibrosil, monoamine oxidase inhibitors, propranolol, tolazamide, and tolbutamide
History of uncontrolled hypertension, congestive heart failure and other cardiovascular disease, liver disease, kidney disease, or any metabolic and clinical disorder, except diabetes mellitus
Patients with dangerous disease
Renal dysfunction (glomerular filtration rate less than 60 ml / min / 1.73 mm3 of surface area)
Participants with recent weight loss or weight gain more than 5% of body weight within 3 months
People with type 1 diabetes or other chronic diseases such as stroke and cancer that may affect physical activity
Pregnant and lactating women
People with psychological illnesses
Patient with type 2 diabetes under insulin therapy
Smoking during the testing period (increasing blood glucose levels)
Patients with sickle cell anemia, thalassemia, Chronic renal failure affecting the hemoglobin A1c
Any circumstances that, according to the researcher, do not justify the participation of individuals in the study